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Viral Nervous Necrosis (VNN) is a neurological disease caused by the Viral Nervous Necrosis 
Virus (VNNV), a member of the Betanodavirus genus, Nodaviridae family, with a genome 
composed of two single-stranded positive-sense RNA molecules (RNA1 and RNA2). This virus 
causes high mortalities in cultured European sea bass (Dicentrarchus labrax), especially during 
larval and juvenile stages. In this study, the susceptibility of 5-g juvenile European sea bass was 
evaluated by intramuscular injection (105 TCID50/g) using isolates belonging to the RGNNV and 
SJNNV genotypes as well as a reassortant isolate (RGNNV RNA1/SJNNV RNA2) obtained from 
Senegalese sole (Solea senegalensis). In these experimental infections, the cumulative mortality 
was determined. Furthermore, quantification of viral genome, by absolute real time PCR, and 
infective viral particles, by virus titration, was performed from brains of dead and survivor fish 
(30 days post-inoculation). In addition, anti-VNNV antibodies in sera from survivor animals were 
determined by indirect ELISA. Typical symptoms of VNN and mortality were only recorded in 
fish inoculated with the RGNNV (47% cumulative mortality) and the reassortant (33%) isolates. 
However, high levels of viral genome and infective viral particles were recorded in brain of 
survivor fish inoculated with the SJNNV isolate, although did not cause mortality or clinical 
signs. Specific antibody response, measured by indirect ELISA, was only observed in the 
VNNV-inoculated groups, with titres of 1/1024, 1/4096 and 1/8192 for RGNNV, SJNNV and 
reassortant inoculated animals, respectively.  
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